These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36490361)

  • 1. p53-Bad* Fusion Gene Therapy Induces Apoptosis In Vitro and Reduces Zebrafish Tumor Burden in Hepatocellular Carcinoma.
    Bowman KER; Ahne L; O'Brien L; Vander Mause ER; Lu P; Wallis B; Evason KJ; Lim CS
    Mol Pharm; 2023 Jan; 20(1):331-340. PubMed ID: 36490361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53-Bad: A Novel Tumor Suppressor/Proapoptotic Factor Hybrid Directed to the Mitochondria for Ovarian Cancer Gene Therapy.
    Lu P; Redd Bowman KE; Brown SM; Joklik-Mcleod M; Vander Mause ER; Nguyen HTN; Lim CS
    Mol Pharm; 2019 Aug; 16(8):3386-3398. PubMed ID: 31241338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver-specific expressions of HBx and src in the p53 mutant trigger hepatocarcinogenesis in zebrafish.
    Lu JW; Yang WY; Tsai SM; Lin YM; Chang PH; Chen JR; Wang HD; Wu JL; Jin SL; Yuh CH
    PLoS One; 2013; 8(10):e76951. PubMed ID: 24130815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SIRT7 regulates hepatocellular carcinoma response to therapy by altering the p53-dependent cell death pathway.
    Zhao J; Wozniak A; Adams A; Cox J; Vittal A; Voss J; Bridges B; Weinman SA; Li Z
    J Exp Clin Cancer Res; 2019 Jun; 38(1):252. PubMed ID: 31196136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-hepatocellular carcinoma effect of Brucea javanica oil in ascitic tumor-bearing mice: The detection of brusatol and its role.
    Wang T; Dou Y; Lin G; Li Q; Nie J; Chen B; Xie J; Su Z; Zeng H; Chen J; Xie Y
    Biomed Pharmacother; 2021 Feb; 134():111122. PubMed ID: 33341052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.
    Wang C; Gao D; Guo K; Kang X; Jiang K; Sun C; Li Y; Sun L; Shu H; Jin G; Sun H; Wu W; Liu Y
    BMC Cancer; 2012 May; 12():166. PubMed ID: 22559167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitro.
    Wang J; Zheng T; Chen X; Song X; Meng X; Bhatta N; Pan S; Jiang H; Liu L
    J Gastroenterol Hepatol; 2011 Feb; 26(2):371-7. PubMed ID: 21261729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous p53 and ASPP2 expression enhances rAdV-TK/ GCV-induced death in hepatocellular carcinoma cells lacking functional p53.
    Liu X; Wang S; Guo X; Wei F; Yin J; Zang Y; Li N; Chen D
    Oncotarget; 2016 Apr; 7(14):18896-905. PubMed ID: 26934443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.
    Ye J; Liang R; Bai T; Lin Y; Mai R; Wei M; Ye X; Li L; Wu F
    J Exp Clin Cancer Res; 2018 Sep; 37(1):212. PubMed ID: 30176896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human adenovirus-p53 injection induced apoptosis in hepatocellular carcinoma cell lines mediated by p53-Fbxw7 pathway, which controls c-Myc and cyclin E.
    Tu K; Zheng X; Zhou Z; Li C; Zhang J; Gao J; Yao Y; Liu Q
    PLoS One; 2013; 8(7):e68574. PubMed ID: 23840897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Valproic Acid on the Class I Histone Deacetylase 1, 2 and 3, Tumor Suppressor Genes p21WAF1/CIP1 and p53, and Intrinsic Mitochondrial Apoptotic Pathway, Pro- (Bax, Bak, and Bim) and anti- (Bcl-2, Bcl-xL, and Mcl-1) Apoptotic Genes Expression, Cell Viability, and Apoptosis Induction in Hepatocellular Carcinoma HepG2 Cell Line.
    Sanaei M; Kavoosi F
    Asian Pac J Cancer Prev; 2021 Feb; 22(S1):89-95. PubMed ID: 33576217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
    Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
    Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CBL0137 administration suppresses human hepatocellular carcinoma cells proliferation and induces apoptosis associated with multiple cell death related proteins.
    Albahde MAH; Zhang P; Chen H; Wang W
    Neoplasma; 2020 May; 67(3):547-556. PubMed ID: 32202904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CP-31398 inhibits the growth of p53-mutated liver cancer cells in vitro and in vivo.
    He XX; Zhang YN; Yan JW; Yan JJ; Wu Q; Song YH
    Tumour Biol; 2016 Jan; 37(1):807-15. PubMed ID: 26250460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
    Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
    Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic inhibitory effects on hepatocellular carcinoma with recombinant human adenovirus Aspp2 and oxaliplatin via p53-independent pathway in vitro and in vivo.
    Liu X; Xu J; Wang S; Yu X; Kou B; Chai M; Zang Y; Chen D
    Int J Oncol; 2017 Oct; 51(4):1291-1299. PubMed ID: 28902369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated tBid overexpression results in therapeutic effects on p53-resistant hepatocellular carcinoma.
    Miao J; Chen GG; Chun SY; Yun JP; Chak EC; Ho RL; Lai PB
    Int J Cancer; 2006 Oct; 119(8):1985-93. PubMed ID: 16708390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interference with the p53 family network contributes to the gain of oncogenic function of mutant p53 in hepatocellular carcinoma.
    Schilling T; Kairat A; Melino G; Krammer PH; Stremmel W; Oren M; Müller M
    Biochem Biophys Res Commun; 2010 Apr; 394(3):817-23. PubMed ID: 20233581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 inhibits tumor cell invasion via the degradation of snail protein in hepatocellular carcinoma.
    Lim SO; Kim H; Jung G
    FEBS Lett; 2010 Jun; 584(11):2231-6. PubMed ID: 20385133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The homeobox transcription factor Prox1 inhibits proliferation of hepatocellular carcinoma cells by inducing p53-dependent senescence-like phenotype.
    Chang TM; Hung WC
    Cancer Biol Ther; 2013 Mar; 14(3):222-9. PubMed ID: 23291986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.